European Penny Stocks To Watch In September 2026

As the European markets navigate through economic uncertainties and rising inflation pressures, investors are keenly observing how these factors influence stock performance. Penny stocks, a term that may seem outdated but still relevant, often refer to smaller or newer companies that can offer unique growth opportunities at lower price points. By focusing on those with strong financial health and potential for growth, investors can uncover hidden gems in this niche market segment.

We'll examine a selection from our screener results.

Faes Farma (BME:FAE)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Faes Farma, S.A. is engaged in the research, development, production, and marketing of pharmaceutical and healthcare products as well as raw materials on an international scale, with a market cap of €1.43 billion.

Operations: The company's revenue is primarily derived from its Pharmaceutical Specialties and Healthcare segment, which generates €620.48 million, followed by the Nutrition and Animal Health segment with €88.10 million.

Market Cap: €1.43B

Faes Farma, S.A. presents a mixed picture for investors interested in penny stocks. The company's revenue is primarily driven by its Pharmaceutical Specialties and Healthcare segment, with sales reaching €382.9 million for the first half of 2026, showing growth from the previous year. However, its return on equity is low at 10.9%, and debt coverage by operating cash flow remains inadequate at 18.2%. While profit margins have declined to 11.8% from last year's 19.4%, Faes Farma trades at a good value relative to peers and maintains high-quality earnings with no significant shareholder dilution recently reported.

• Click to explore a detailed breakdown of our findings in Faes Farma's financial health report.
• Gain insights into Faes Farma's future direction by reviewing our growth report.

High (ENXTPA:HCO)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: High Co. SA operates in the retail agencies, retail media, and retail activation sectors in France and Belgium with a market capitalization of €71.08 million.

Operations: Revenue Segments: No specific revenue segments have been reported for High Co. SA.

Market Cap: €71.08M

High Co. SA's recent earnings report shows a challenging landscape for investors in penny stocks. Despite sales increasing to €57.65 million for the half-year ending June 2026, the company recorded a net loss of €0.938 million, contrasting with last year's profit of €4.46 million. The company's debt is well covered by operating cash flow, and it holds more cash than total debt, indicating financial resilience despite increased debt-to-equity ratios over five years. However, declining profit margins and negative earnings growth underscore potential risks, while its dividend remains unsustainably high relative to earnings coverage.

• Click here to discover the nuances of High with our detailed analytical financial health report.
• Examine High's earnings growth report to understand how analysts expect it to perform.

Hub.Tech (WSE:HUB)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Hub.Tech SA is a Polish company operating in the chemical industry with a market capitalization of PLN188.23 million.

Operations: The company generates revenue from its Specialty Chemicals segment, amounting to PLN269.20 million.

Market Cap: PLN188.23M

Hub.Tech SA, a Polish chemical company with a market cap of PLN188.23 million, presents a mixed picture for penny stock investors. Despite being debt-free and having short-term assets significantly exceeding liabilities, the company's earnings growth has been negative over the past year with profit margins dropping from 10.9% to 4.2%. Recent earnings reports show an increase in revenue to PLN158.13 million for the first half of 2026 compared to last year, but net income declined from PLN20.62 million to PLN16.82 million due to large one-off losses impacting financial results and low return on equity at 3.5%.

• Navigate through the intricacies of Hub.Tech with our comprehensive balance sheet health report here.
• Gain insights into Hub.Tech's past trends and performance with our report on the company's historical track record.

Summing It All Up

• Jump into our full catalog of 306 European Penny Stocks here.
• Contemplating Other Strategies? Outshine the giants: these 17 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com